Jonathan Davis, PhD, brings more than 20 years of experience in the life science industry to Invenra, having focused his career on protein and antibody engineering, bispecific and multispecific antibody platform development, and drug discovery across a wide range of therapeutic areas. Prior to joining the Invenra SAB, Jonathan was Vice President of Innovation and Strategy for Invenra where he focused on optimization of the B-Body Platform, the development of antibody libraries, and refinements to screening methodology and throughput. Prior to Invenra, he was a Principal Scientist at Bristol-Myers Squibb, where he worked on all aspects of biologic drug design, including successfully designing a trispecific HIV biotherapeutic. Prior to that, he worked at EMD Serono, where he developed a variety of novel biologic drug platforms. Jonathan received a BA in music from Reed College, earned a PhD. in Biophysics from the University of California, San Francisco, and completed a post-doctoral fellowship at Harvard Medical School.
